GB2125033B - Cephalosporins - Google Patents

Cephalosporins

Info

Publication number
GB2125033B
GB2125033B GB08318978A GB8318978A GB2125033B GB 2125033 B GB2125033 B GB 2125033B GB 08318978 A GB08318978 A GB 08318978A GB 8318978 A GB8318978 A GB 8318978A GB 2125033 B GB2125033 B GB 2125033B
Authority
GB
United Kingdom
Prior art keywords
cephalosporins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08318978A
Other versions
GB2125033A (en
GB8318978D0 (en
Inventor
Ivan Csendes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Servipharm Ltd
Sandoz AG
Original Assignee
Servipharm Ltd
Servipharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servipharm Ltd, Servipharm AG filed Critical Servipharm Ltd
Publication of GB8318978D0 publication Critical patent/GB8318978D0/en
Publication of GB2125033A publication Critical patent/GB2125033A/en
Application granted granted Critical
Publication of GB2125033B publication Critical patent/GB2125033B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GB08318978A 1982-07-23 1983-07-13 Cephalosporins Expired GB2125033B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH452982 1982-07-23

Publications (3)

Publication Number Publication Date
GB8318978D0 GB8318978D0 (en) 1983-08-17
GB2125033A GB2125033A (en) 1984-02-29
GB2125033B true GB2125033B (en) 1985-08-29

Family

ID=4277796

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08318978A Expired GB2125033B (en) 1982-07-23 1983-07-13 Cephalosporins

Country Status (7)

Country Link
JP (1) JPS59144786A (en)
BE (1) BE897360A (en)
DE (1) DE3326194A1 (en)
FR (1) FR2530635B1 (en)
GB (1) GB2125033B (en)
IT (1) IT1168615B (en)
NL (1) NL8302624A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86107947A (en) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 New cephem compounds and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
CA1088049A (en) * 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
FI800381A (en) * 1979-02-16 1980-08-17 Sandoz Ag NYA KEFALOSPORINDERIVAT DERAS FRAMSTAELLNING OCH ANVAENDNING SOM ANTIMIKROBIELLA AEMNEN

Also Published As

Publication number Publication date
IT1168615B (en) 1987-05-20
FR2530635B1 (en) 1986-05-16
IT8348726A0 (en) 1983-07-21
GB2125033A (en) 1984-02-29
DE3326194A1 (en) 1984-01-26
FR2530635A1 (en) 1984-01-27
BE897360A (en) 1984-01-25
NL8302624A (en) 1984-02-16
GB8318978D0 (en) 1983-08-17
JPS59144786A (en) 1984-08-18

Similar Documents

Publication Publication Date Title
ZA831390B (en) Cephalosporin compounds
GB8402249D0 (en) Cephalosporins
AU564971B2 (en) Cephalosporins
GB8324081D0 (en) Cephem compounds
GB8331713D0 (en) Cephem compounds
GB2148289B (en) 3-bicyclicpyridinium-methyl cephalosporins
GB8419202D0 (en) Cephalosporins
GB8330745D0 (en) Cephem compounds
AR242637A1 (en) Staking-machine
GB2131800B (en) Cephalosporins
GB2125033B (en) Cephalosporins
GB2131799B (en) Cephalosporin compounds
PH17982A (en) Cephalosporins
AU1267983A (en) Cephalosporins
ZA834759B (en) Cephalosporin compounds
IE822600L (en) Cephalosporin
PH16811A (en) Cephalosporin
IE821424L (en) Penicillins
IE830645L (en) Cephalosporins
IE832471L (en) Cephalosporins
IE822361L (en) Cephalosporin compounds
IE801798L (en) Cephalosporins
IE802565L (en) Cephalosporins
IE812115L (en) Cephalosporins
PH16704A (en) Cephalosporins

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee